Company News
Friday preview: Global factory PMIs, IMI in focus
Barring surprises, the spotlight at the end of the week is expected to be on Caixin's closely-followed factory sector Purchasing Managers' Index for the month of February.
BAT earnings growth heats up, finance chief retires
British American Tobacco grew underlying earnings above its target range last year despite cigarette volumes declining 3. 5% as it predicted.
Aston Martin expects continued sales growth, IPO costs hit profits
Aston Martin Lagonda Global reported good underlying growth in its the first results since its 2018 flotation, though fell to a statutory loss due to listing costs.
Rolls-Royce posts £1.2bn loss after engine troubles, restructuring
Rolls-Royce made a loss at the bottom line due to sizeable one-off charges but ended 2018 with a pile of cash after axing around 1,300 jobs and selling off its fuel injection business.
Inmarsat surges on report of renewed EchoStar interest
Shares in Inmarsat rallied on Thursday after CTFN cited a senior executive in the sector as saying that US rival EchoStar may renew its interest in the satellite communications company soon and no later than the next six months.
Immotion Group signs distribution deal for Middle East and North Africa
Virtual reality (VR) attraction company Immotion Group has appointed Dubai-based Warehouse of Games as its exclusive distribution partner for the Middle East and North Africa (MENA) territories, it announced on Thursday.
US consumer demand leads to more fragrant Byotrol variant
Specialist anti-microbial technology company Byotrol has completed the product registration process in the United States for two new, improved versions of its 24-hour germ-kill surface sanitiser, 'Byotrol24’, it announced on Thursday.
Amryt gets approval to extend EASE trial to infants and children
Orphan drug company Amryt Pharma updated the market on its phase 3 ‘EASE’ trial for AP101 as a potential treatment for epidermolysis bullosa (EB) on Thursday, reporting that following an assessment by the trial's independent data monitoring committee, it could now enrol infants and children with EB between the ages of 21 days to four years in the trial.
Sareum flags potentially significant findings for SRA737
Specialist small molecule drug development company Sareum Holdings announced on Thursday that Sierra Oncology, the licence holder advancing clinical cancer candidate SRA737, had reported that an abstract reporting preclinical data for SRA737 - its Chk1 inhibitor - plus low dose gemcitabine (LDG), in combination with immunotherapy, had been selected for a late-breaking oral presentation at the American Association of Cancer Research annual meeting.
GoCompare profit and revenue rise, plans £10m investment in weflip
Price comparison website GoCompare posted a rise in full-year operating profit and revenue on Thursday as it announced a £10m investment in its weflip service.
Conroy Gold narrows losses, project development continues
Ireland-based resource company Conroy Gold and Natural Resources narrowed losses in the first half of its trading year.
Applied Graphene soars on 'fivefold' technology improvement
Applied Graphene Materials' (AGM) shares shot up on Thursday after the business announced that its breakthrough graphene technology has delivered "outstanding" anti-corrosion performance enhancement results that has led the business to be nominated for a key industry award.
Foxtons swings to a loss as London sales market struggles
Foxtons said on Thursday that it swung to a loss in 2018 as it warned that the London sales market is in "a prolonged downturn".
Itaconix leaps on second Nouryon supply agreement
Itaconix's shares soared on Thursday after the business signed a supply agreement for its bio-based polymers with chemical firm Nouryon.
Genus swings to loss after being hit by pension charges
Genus on Thursday confirmed that it swung to an interim loss as revenue remained flat as the livestock genetics specialist was hit by non-cash accounting charges and the effects of the rapid spread of African Swine Fever in China.
Telford cuts £10m off full-year profit guidance
Residential property developer Telford Homes slashed its full-year profit guidance by a minimum of £10m on Thursday, sending its shares south.
Greencoat puts in decent performance despite lack of wind
Greencoat UK Wind said it performed in line with its expectations in its results for 2018 on Thursday, with cash generation on budget.
CCPI acquisition sees Vesuvius expand in aluminium
Molten metal flow engineering and technology Vesuvius announced on Thursday that it has agreed to acquire CCPI - a specialty refractory producer focused on tundish applications and aluminium.
Vesuvius outperforms underlying markets in steel and foundry
Vesuvius announced a 10. 7% improvement in its underlying revenue in its annual results on Thursday, to £1. 798bn, reporting that both its steel and foundry divisions outperformed their underlying markets.
Petrofac runs down debt ahead of schedule, but cites near-term uncertainty
Petrofac managed to erase its net debt last year, witht falling revenues and profitability offset by asset sales.